The Danish-Sino initiatives to open the genome and the gut microbiome to improve cardiovascular health of the at-risk population.
The Danish-Sino initiatives aim to read the human genome and the gut microbiome to improve metabolic and cardiovascular health of the at-risk population
LUCAMP is funded by a 5 year grant from the Lundbeck Foundation. The research consortium has scientists from Hagedorn Research Institute, Steno Diabetes Center, Danish Universities and Beijing Genomics Institute. LUCAMP was established in late 2007 and was designed to: - discover and characterize novel variation in the human genome conferring an increased risk of visceral obesity, type 2 diabetes and hypertension and eventually premature cardiovascular disorders and death - discover and characterize novel variation in the human gut microbiome influencing metabolic and cardiovascular health - investigate how the novel molecular signatures interact mutually and with other risk markers, particularly in health behaviour, influencing the risk of developing widespread metabolic disorders - investigate how these discoveries may help improve metabolic and cardiovascular health in the at-risk population